The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and ...
Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or ...
President Joe Biden has proposed expanding Medicare and Medicaid coverage for anti-obesity drugs to over 7 million Americans.
The Biden administration is looking to extend Medicare and Medicaid coverage to include obesity drugs like Wegovy and Zepbound. Weight loss drugs are now excluded from mandatory coverage.
If made official, the proposed rule would give Part D and Medicaid beneficiaries expanded coverage to antiobesity drugs ...
US President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid, ...
Shares of weight-loss drugmakers Novo Nordisk and Eli Lilly rose on Tuesday after U.S. President Joe Biden proposed expanding ...
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...